LINC02505

Across TCGA pan-cancer cohorts, LINC02505 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02505’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02505 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02505 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC, BRCA, and LUSC are the cancer types where LINC02505 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02505 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.021	.002	4	view →
BRCA	All	All	+0.015	.013	4	view →
LUSC	All	All	+0.214	.006	2	view →
LUAD	All	All	+0.123	.036	1	view →
LIHC	All	All	+0.084	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02505–KIRC

Open the KIRC breakdown →